Across TCGA pan-cancer cohorts, EFCAB14P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of EFCAB14P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EFCAB14P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EFCAB14P1 is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

COAD, THCA, and LUSC are the cancer types where EFCAB14P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EFCAB14P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.144	.011	4	view →
THCA	All	All	−0.051	.004	3	view →
LUSC	Female	All	+0.129	.030	2	view →
KIRP	Male	All	−0.091	.015	2	view →
LIHC	All	All	+0.037	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: EFCAB14P1 RNA expression & survival · all EFCAB14P1 data types